-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Encompass Health, Raises Price Target to $155

Benzinga·08/07/2026 23:37:54
Listen to the news
UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $155.